EcoDrugPlus

Ensembl ID : ENSHHUG00000045686
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSHHUG00000014175
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSHHUG00000014027
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSHHUG00000045896
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSHHUG00000014013
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSHHUG00000001937
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSHHUG00000013940
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSHHUG00000004683
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSHHUG00000022557
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSHHUG00000012291
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSHHUG00000022835
Gene Symbol: -
Cross references: -
117 Possible Orthologues:

Ensembl ID : ENSHHUG00000022909
Gene Symbol: -
Cross references: -
148 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).